Active — Not RecruitingNot Applicable

Elastofibroma Dorsi: Clinical Features, Surgical Outcomes, and Risk Factors

130 participantsStarted 2010-01-01

Plain-language summary

This study aims to retrospectively evaluate patients who underwent surgical treatment for elastofibroma dorsi, a rare benign tumor typically located in the subscapular region of the chest wall. The study will analyze demographic and clinical features, risk factors, diagnostic imaging methods, postoperative complications, and recurrence rates. By identifying potential predictors of complications and recurrence, the study hopes to contribute to the understanding and management of this silent and often incidental lesion.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who underwent surgical treatment for elastofibroma dorsi * Histopathological confirmation of the diagnosis * Minimum of 1-month postoperative follow-up available * Age 18 years or older * Accessible medical and imaging records in hospital archives * Signed informed consent available in patient records (if applicable) Exclusion Criteria: * Patients diagnosed with elastofibroma dorsi but not treated surgically * Cases without histopathological confirmation * Incomplete or insufficient medical and radiological records * Postoperative follow-up period less than 1 month * Patients younger than 18 years * Absence of documented informed consent (if applicable)

What they're measuring

Completion of Retrospective Data Collection Form

Timeframe: Within 3 months after data collection begins

Trial details

NCT IDNCT07010224

SponsorOndokuz Mayıs University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-09-30

View on ClinicalTrials.gov More Elastofibroma Dorsi trials